Vaccines represent one of the most effective measures of public health medicine, saving
countless lives and preventing lifelong disabilities. Vaccines are extremely safe, however …

Background The objective of this study is to assess cases of thrombocytopenia, including
immune thrombocytopenia (ITP), reported to the Vaccine Adverse Event Reporting System …

There is concern that COVID‐19 vaccination may adversely affect immune
thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were …

The rollout of the SARS-CoV-2 vaccine is underway, and millions have already been
vaccinated. At least 25 reports of “immune thrombocytopenia”(ITP) or “thrombocytopenia” …

Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its …

Emerging evidence suggest a possible association between immune thrombocytopenia
(ITP) and some formulations of COVID-19 vaccine. We conducted a retrospective case …

Australia and New Zealand have achieved excellent community control of COVID‐19
infection. In light of the imminent COVID‐19 vaccination roll out in both countries …

Vaccination programmes are of vital importance to public health and are present in virtually
every country in the world. By promoting an understanding of the diverse effects of …

We present a case of immune thrombocytopenia (ITP) induced by the chimpanzee
adenovirus-vectored vaccine, without evidence of thrombosis, eight days after vaccine …

Immune thrombocytopenic purpura (ITP) is a rare complication associated with vaccines
targeting various diseases, including influenza, measles‐mumps‐rubella, hepatitis B, and …